Tekla Life Sciences Investors (HQL) Financials

HQL Assets vs Liabilities
DateAssetsLiabilities
March 31, 2024 441.9 million 879912
Dec. 31, 2023 ? ?
Sept. 30, 2023 402.6 million 666959
March 31, 2023 432.7 million 10.0 million

HQL Free Cash Flow and Stock based compensation

No data available :(

HQL Net Income
Graph available only for supporters. Become a supporter to see it.
DateNet Income
March 31, 2024 ?
Dec. 31, 2023 ?
Sept. 30, 2023 -11.5 million
March 31, 2023 16901

HQL Cash and Debt
Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
March 31, 2024 13.8 million - -
Dec. 31, 2023 - - -
Sept. 30, 2023 477 - -
March 31, 2023 822 - -

HQL Shares Outstanding
Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
March 31, 2024 27.4 million
Dec. 31, 2023 27.4 million
Sept. 30, 2023 26.8 million
March 31, 2023 26.2 million

HQL Expenses
Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
March 31, 2024 - - 1.4 million 4057
Dec. 31, 2023 - - 1.4 million 4057
Sept. 30, 2023 - - - -
March 31, 2023 - - 1.4 million -

HQL Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
March 31, 2024 -225192 2.5 million
Dec. 31, 2023 1.0 million -
Sept. 30, 2023 29.6 million 2.6 million
March 31, 2023 9.8 million 2.7 million

HQL

Price: $12.85

52 week price:
10.55
15.90

Forward Dividend Yield: 13.39%

Payout Ratio: 146.27%

Dividend Per Share: 1.72 USD

Earnings Per Share: 3.04 USD

P/E Ratio: 4.18

Exchange: NYQ

Sector: Financial Services

Industry: Asset Management

Volume: 93486

Market Capitalization: 366.5 million

Average Dividend Frequency: 4

Years Paying Dividends: 30

DGR3: -2.15%

DGR5: 0.60%

DGR10: 0.22%

DGR20: 20.88%

Links: